跳至主要内容
临床试验/NCT05858957
NCT05858957已完成4 期

The Effect of Magnesium Sulfate on Extubation Quality Score and Recovery in Larynx Laser Microsurgery, Prospective, Randomized, Controlled Study

Cukurova University1 个研究点 分布在 1 个国家目标入组 98 人开始时间: 2023年4月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
98
试验地点
1
主要终点
extubation quality scores

研究概览

简要总结

The investigators aimed to search effect of magnesium Sulfate on extubation quality scores, recovery and pain in larynx micro surgery. The patients allocated to two groups to receive magnesium sulfate 30 mg/kg in 100 ml saline infusion (maximum 2g) (Group m) or saline 100 ml (Group S) before induction of anesthesia. Anesthesia induction performed with propofol 2 mg/kg, rocuronium 0.6 mg/kg, remifentanil 0.5 µg/kg and general anesthesia maintained with total intravenous anesthesia (propofol 3-7 mg/kg, remifentanil 0.05-0.1 µg/kg/min and O2/air 30/70 mixture) to the all patients. Extubation quality scores, Extubation time, NRS scores were assessed.

详细描述

The investigators aimed to search effect of magnesium sulfate on extubation quality, recovery feature and complications.98 adult patients scheduled for larynx laser microsurgery were included and randomly allocated to two groups to receive magnesium sulfate 30 mg/kg in 100 ml saline infusion (maximum 2g) (Group m) or saline 100 ml (Group S) before induction of anesthesia. Anesthesia induction performed with propofol 2 mg/kg, rocuronium 0.6 mg/kg, remifentanil 0.5 µg/kg and general anesthesia maintained with total intravenous anesthesia (propofol 3-7 mg/kg, remifentanil 0.05-0.1 µg/kg/min and O2/air 30/70 mixture) to the all patients. Paracetamol 15 mg/kg applied to all patients.Extubation quality score, extubation time, stay in postanesthesia unit (PACU) time, numeric rating scale (NRS) and complications were recorded.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 age over
  • American society of Anesthesiology (ASA) clinical status I-III
  • the patients who experience larynx micro surgery

排除标准

  • under 18 years old
  • ASA IV and over
  • severe airway obstruction
  • neuromuscular disease
  • presence of tracheostomy

研究组 & 干预措施

Magnesium

Experimental

Magnesium sulfate 30 mg/kg with 100 ml saline will apply in 10 min before induction of general anesthesia (maximum magnesium dose 2g) (Group M) . When the magnesium infusion completed, general anesthesia induction will start.

干预措施: Magnesium sulfate (Drug)

Saline

Active Comparator

saline 100 ml will apply in 10 min before induction of general anesthesia (Group S) . When the saline infusion completed, general anesthesia induction will start.

干预措施: Saline (Drug)

结局指标

主要结局

extubation quality scores

时间窗: at the time between stop the total intravenous anesthesia and extubation of patient (last 20 min of anesthesia).

Extubation quality will assess with quality scores such as no cough, Mild cough, moderate cough, severe cough.

次要结局

  • extubation time(time between stop the total intravenous anesthesia and extubation of patient (last 20 min of anesthesia).)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

ebru biricik

Associate professor

Cukurova University

研究点 (1)

Loading locations...

相似试验